Meridian's Fiscal Q1 Preliminary Results Fall Short of Expectations | GenomeWeb

NEW YORK (GenomeWeb News) - Meridian Bioscience today reported $44.8 million in preliminary revenue for its fiscal first quarter, marking a 1 percent decline from the year-ago period and falling short of consensus analyst estimates of $49 million.

The company attributed the disappointing results to several factors, including reduced hospital admissions, declining C. difficile incidence rates, shipment delays in its Life Science business, timing of the start of the influenza season, and food test ordering patterns.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.